- Filed
- May 15, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 15, 2025 | 96.23M sh |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $9.48M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $8.81M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $9.73M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $9.07M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $5.2M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $6.1M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $9.3M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $10.26M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 94.36M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $0 |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$439.22K |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2024 | $8.8M |
| Stockholders Equity restated | Q1 2025 · Dec 31, 2023 | $60.35K |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.03 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $3.53M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $0 |
| Net Income restated | Q1 2025 · Mar 31, 2024 | −$2.85M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$2.4M |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $1.13M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $2.11M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $3.24M |